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SUMMARY Incontinentia pigmenti or Bloch-Sulzberger 
syndrome is a rare X-linked dominant disorder with charac-
teristic skin, hair, eye, dental and neurologic abnormalities 
mostly affecting females. We report a case of a female new-
born exhibiting characteristic cutaneous and neurologic 
findings with one-year follow-up.
KeY woRdS: incontinentia pigmenti, NEMO/IKBKG, new-
born
IntRodUCtIon
Incontinentia pigmenti (IP), also known as Bloch-
Sulzberger syndrome, is a rare X-linked dominant 
genodermatosis. It is a multisystem, ectodermal and 
mesodermal disorder accompanied by dermatologic, 
dental and ocular features and in a minority of cases 
may be associated with neurologic deficit (1-4). Mu-
tation of NEMO (NF-kappa-B essential modulator), 
also known as IKK-γ/IKBKG (inhibitor of nuclear fac-
tor kappa-B kinase subunit gamma) gene located on 
chromosome Xq28 is believed to play a role in the 
pathogenesis (5). NEMO/IKK-γ helps activate NF-κB, 
which controls the expression of multiple genes, in-
cluding cytokines and chemokines, and protects cells 
against apoptosis (6-8). A lack of NEMO/IKK-γ there-
fore causes a lack of active NF-κB, which makes cells 
more prone to apoptosis.
In this report, we describe a case of IP in a female 
infant with dermatologic and neurologic signs of ear-
ly onset neonatal seizures and verrucous skin lesions.
CASe RePoRt
A of 19-day-old female infant was born at full-
term by normal vaginal delivery with no history of 
consanguinity in the parents. The baby was referred 
to the hospital for evaluation of seizures and abnor-
mal skin lesions. According to her parents, the infant 
developed partial seizures in the arms, legs and face 
about 10 times before coming to the hospital. Each 
time, the seizures lasted for 1 to 2 minutes. The girl 
was also reported to have erythematous vesicular 
eruptions on the upper and lower extremities since 
she had been 12 days old. Skin lesions were noticed 
to be of a linear pattern, mostly seen on the limbs, 
and developed increasingly over the next 7 days 
(Figs. 1 and 2). The mother denied the presence of 
any skin rash at birth. There was no history of fever or 
cold since the infant’s birth.
The mother was a healthy G2P1 with a history of 
spontaneous abortion. She denied any similar sign 
in family members. However, the mother presented 
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system revealed nothing abnormal. Histopathology 
of a skin biopsy showed spongiotic dermatitis with 
massive intraepidermal eosinophilia in the presence 
of eosinophil-filled intraepidermal vesicles, as well as 
infiltrate of lymphocytes in superficial dermis (Fig. 3).
Based on all these findings, definitive diagnosis 
was IP. The seizures were treated with phenobarbital 
and no special treatment was administered for her 
skin lesions. The seizures ceased after 2 days of an-
tiepileptic treatment. She stayed in the hospital for 
another 10 days for observation and no other central 
nervous system reflection abnormality was detected. 
Then the patient was discharged from the hospital, 
Figure 1. Linear vesiculobullous skin eruption with 
erythematous base on both legs on the first day of 
the patient’s presentation to the hospital.
some faint hypopigmented atrophic linear lesions on 
both thighs, which she believed had appeared in her 
childhood.
Laboratory tests revealed no abnormalities in 
whole blood count, C-reactive protein, serum elec-
trolytes and glucose, although eosinophil count was 
as high as 32% (normal range, 0-10%). The infectious 
cause was excluded (VDRL test performed in the 
child and her parents was non-reactive). Electroen-
cephalogram (EEG) showed epileptiform discharges 
with sharp waves and sharp, slow complex waves in 
the right hemisphere. However, computed tomogra-
phy (CT) scans of the brain appeared normal. Other 
systemic examination including ocular and skeletal 
Figure 2. Multiple vesicles, firm and yellowish, with 
inflammatory linear distribution on the left leg. 
Figure 3. Histopathology of the skin biopsy showed spongiotic dermatitis with massive intraepidermal eosino-
philia in the presence of eosinophil-filled intraepidermal vesicles, as well as the infiltrate of lymphocytes in su-
perficial dermis (A-C); (hematoxylin and eosin staining; original magnifications: A, ×10; B, ×20; C, ×40).
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while her skin lesions mostly became verrucous with 
additional hyperpigmented streaks (Figs. 4 and 5). 
There were no new skin rashes. 
At present, the girl is aged 16 months and under-
going complete medical follow-up on a regular out-
patient basis including checkups at departments of 
pediatrics, dermatology, ophthalmology, and reha-
bilitation medicine.
dISCUSSIon
Incontinentia pigmenti is inherited in an X-linked 
dominant manner. Therefore, more than 95% of the 
patients are female infants (9). In males, it is usually 
lethal and most of the affected male fetuses result in 
miscarriage or stillbirth (4). Rarely affected surviving 
males are attributed to the presence of an extra X 
chromosome (Klinefelter’s syndrome/XXY syndrome) 
or as a result of a mutation in some of the body’s cells 
(somatic mosaicism) with relatively mild effects (10). 
In our case, although there was no information on 
the fetus’s sex, the history of miscarriages might be 
a result of IP. Incontinentia pigmenti is hereditary in 
10%-25% of cases (11).
Dermatologic findings are often the first observed 
sign of IP and are present in nearly all patients (7). 
In most cases, the onset of skin changes is before 6 
weeks of age (4). Progressive cutaneous manifesta-
tions are the main clinical feature of the disease and 
classically evolve through 4 stages. However, their 
sequence is irregular and some of may overlap with 
others or not appear at all. Stage 1 (vesicular stage) is 
presented at birth or within the first 2 weeks in 90% 
of patients and is characterized by a rash of erythem-
atous blisters, which often appear to be grouped 
along the lines of Blaschko. Biopsy characteristically 
exhibits spongiotic dermatitis with massive intraepi-
dermal and dermal eosinophilia (7). Stage 2 (verru-
cous stage) occurs in about 70% of patients. Eruption 
of hyperkeratotic verrucous papules and plaques 
develops over the healing blisters. It usually appears 
within 2 months and disappears within 6 months. 
Hyperkeratosis, dyskeratosis, acanthosis and papil-
lomatosis are present in this stage (11,12). Stage 3 
(hyperpigmented stage) is classically the hallmark 
of IP. Nearly 98% of patients experience stage 3. Pig-
mentation ranges from blue-grey or slate to brown, 
and occurs in streaks or whorls. It generally develops 
within the first few months of life and tends to fade 
by adolescence. Melanophages in the dermis and 
vacuolization of basal cells is the most common find-
ing (4,13). Stage 4 (atrophic/hypopigmented stage) 
occurs in adolescence and persists into adulthood. 
Pale, hairless patches or streaks, sometimes scar-like 
lesions are mostly found on lower legs. Such changes 
are mostly permanent and often the only sign of skin 
involvement in adult patients. It presents as atrophy 
and thinning of the epidermis with the absence of 
skin appendages (4,14-16).
The vesicular stage is most often observed at birth 
or within the first two weeks of life in IP, which coin-
cides with our case. The patient presented with stage 
1 and gradually developed to stages 2 and 3. Accord-
ing to the follow-up, we believe that the hyperpig-
mented stage is still the current clinical presentation 
of the patient. Since the patient is only 16-month-old, 
she may still develop into stage 4. 
Cutaneous lesions may also be accompanied 
by defects of cutaneous appendages in the form of 
vertex alopecia, ridged, pitted, or dystrophic nails 
Figure 4. Hyperpigmented lesions on the left leg 
following the lines of Blaschko ten days after the pa-
tient’s admission to the hospital. 
Figure 5. Verrucous lesions with hyperpigmented 
streaks of the leg ten days after the patient’s admis-
sion to the hospital.
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(17). Extracutaneous manifestations occur in various 
ways in about 70%-80% of IP patients. Dental abnor-
malities are the most common types and affect more 
than 80% of patients with delayed dentition, partial 
anodontia, cone or peg shaped teeth or absence of 
teeth. Some 30%-50% of patients exhibit neurologic 
deficiency, identified as seizures, mental retardation, 
developmental delays, spastic paralysis, ataxia and 
motor dysfunction (18-20). Ocular abnormalities are 
also observed in around 30% of patients including 
strabismus, cataracts, optic atrophy, retinal dysfunc-
tion, uveitis, nystagmus and blindness. Skeletal and 
structural anomalies have occasionally been reported 
as well, such as somatic asymmetry, skull deformities, 
spina bifida, dwarfism, syndactyly, extra ribs, primary 
pulmonary hypertension, and cardiopulmonary fail-
ure. Keratotic tumors in late adolescence may invo-
lute spontaneously. Several cases of IP have been as-
sociated with cancer in childhood (21,22).
In our case, seizure was one of the first manifesta-
tions of the disease but no other signs were present. 
However, the presence of central nervous system in-
volvement in the neonatal period is believed to be a 
poor prognostic sign. Anomalies may not appear at 
the initial evaluation but later on. Therefore, long-
term follow-up with dermatology, pediatrics, neurol-
ogy, ophthalmology and dentistry is crucial.
There are no standardized diagnostic criteria for 
IP yet. The diagnosis relies mostly on the characteris-
tic skin lesions and other clinical findings. Therefore, 
timely recognition of IP by pediatricians and derma-
tologists is crucial. Skin biopsy and molecular genetic 
testing of the NEMO gene may help confirm the dis-
ease. Family history or a history of multiple miscar-
riages also supports the diagnosis of IP.
There is not specific treatment for IP yet. Although 
skin lesions are the most common manifestations 
and one of the most important aspects of the diag-
nosis, they are actually less damaging to the patients 
and tend to heal spontaneously. The management of 
systemic abnormalities is based on symptomatology. 
Support and corrective treatment should be used 
whenever possible. 
ConCLUSSIon 
Long-term and close cooperation between der-
matologists, pediatricians, neurologists, genetic 
counselors, and even dentists is crucial for better un-
derstanding of IP and prediction of the occurrence of 
the potential anomalies later in life (13). 
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